A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden

被引:131
作者
Karlström, O
Fryklund, B
Tullus, K
Burman, LG [1 ]
机构
[1] Swedish Inst Infect Dis Control, S-10521 Stockholm, Sweden
[2] St Gorans Childrens Hosp, Dept Pediat, S-11281 Stockholm, Sweden
关键词
D O I
10.1086/516277
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clostridium difficile-associated diarrhea (CDAD) is regarded as an emerging nosocomial infection. All patients positive for C. difficile in Sweden were recorded during 1995, including primary care patients. Those positive for toxin in feces were defined as CDAD cases. A total of 5,133 CDAD cases were recorded (58 per 100,000 inhabitants per year), as compared with 86 cases diagnosed in 1978 and 553 in 1983. CDAD was almost twice as prevalent as all (combined) diagnosed domestic cases of reportable bacterial and protozoal diarrhea. The age-specific incidence was little affected by gender but increased >10-fold over the age range of 60-98 years. The differences in overall CDAD incidence were sixfold between counties and threefold between major hospitals. Among hospitalized patients the incidences were highest in geriatric/rehabilitation wards, followed by infectious diseases and internal medicine wards; 28% of all cases involved no recent hospitalization and were defined as community-acquired CDAD.
引用
收藏
页码:141 / 145
页数:5
相关论文
共 27 条
  • [1] ANAND A, 1994, AM J GASTROENTEROL, V89, P519
  • [2] [Anonymous], 1995, INFECT CONT HOSP EP, V16, P105
  • [3] ROLE OF CLOSTRIDIUM-DIFFICILE IN CHILDHOOD DIARRHEA
    CERQUETTI, M
    BIOL, D
    LUZZI, I
    CAPRIOLI, A
    SEBASTIANELLI, A
    MASTRANTONIO, P
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (07) : 598 - 603
  • [4] PRESENCE OF CLOSTRIDIUM-DIFFICILE AND ANTIBIOTIC AND BETA-LACTAMASE ACTIVITIES IN FECES OF VOLUNTEERS TREATED WITH ORAL CEFIXIME, ORAL CEFPODOXIME PROXETIL, OR PLACEBO
    CHACHATY, E
    DEPITRE, C
    MARIO, N
    BOURNEIX, C
    SAULNIER, P
    CORTHIER, G
    ANDREMONT, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) : 2009 - 2013
  • [5] Recurrent Clostridium difficile diarrhea: Characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial
    Fekety, R
    McFarland, LV
    Surawicz, CM
    Greenberg, RN
    Elmer, GW
    Mulligan, ME
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) : 324 - 333
  • [6] BOWEL FLORA CHANGES IN HUMANS RECEIVING CEFIXIME (CL-284635) OR CEFACLOR
    FINEGOLD, SM
    INGRAMDRAKE, L
    GEE, R
    REINHARDT, J
    EDELSTEIN, MAC
    MACDONALD, K
    WEXLER, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (03) : 443 - 446
  • [7] GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459
  • [8] EPIDEMIOLOGY OF COMMUNITY-ACQUIRED CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHEA
    HIRSCHHORN, LR
    TRNKA, Y
    ONDERDONK, A
    LEE, MLT
    PLATT, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) : 127 - 133
  • [9] CLOSTRIDIUM-DIFFICILE COLITIS - AN INCREASING HOSPITAL-ACQUIRED ILLNESS
    JOBE, BA
    GRASLEY, A
    DEVENEY, KE
    DEVENEY, CW
    SHEPPARD, BC
    [J]. AMERICAN JOURNAL OF SURGERY, 1995, 169 (05) : 480 - 483
  • [10] NOSOCOMIAL CLOSTRIDIUM-DIFFICILE COLONIZATION AND DISEASE
    JOHNSON, S
    CLABOTS, CR
    LINN, FV
    OLSON, MM
    PETERSON, LR
    GERDING, DN
    [J]. LANCET, 1990, 336 (8707) : 97 - 100